Activation of Apoptotic Caspase Cascade During the Transition to Pressure Overload-Induced Heart Failure

Journal of the American College of Cardiology

Volumn 48, Issue 7, 2006, Pages 1451-1458

  Moorjani, Narain ^a   Ahmad, Manzoor ^b   Catarino, Pedro ^a   Brittin, Robin ^c   Trabzuni, Danyah ^b   Al Mohanna, Futwan ^b   Narula, Navneet ^d   Narula, Jagat ^d   Westaby, Stephen ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CASPASE 9; DNA FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA STENOSIS; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEART VENTRICLE FUNCTION; HEART VENTRICLE PRESSURE; IMMUNOHISTOCHEMISTRY; MALE; MYOCARDIAL DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANIMALS; AORTIC VALVE STENOSIS; APOPTOSIS; CARDIAC OUTPUT, LOW; CASPASES; DISEASE PROGRESSION; DNA DAMAGE; HYPERTROPHY, LEFT VENTRICULAR; MALE; MYOCYTES, CARDIAC; SHEEP; VENTRICULAR PRESSURE;

EID: 33748935720     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.05.065     Document Type: Article

References (36)

1. Reed J.C. Mechanisms of apoptosis. Am J Pathol 157 (2000) 1415-1430
2. Cook S.A., and Poole-Wilson P.A. Cardiac myocyte apoptosis. Eur Heart J 20 (1999) 1619-1629
3. Ashkenazi A., and Dixit V.M. Death receptors: signaling and modulation. Science 281 (1998) 1305-1308
4. Kluck R.M., Bossy-Wetzel E., Green D.R., and Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275 (1997) 1132-1136
5. Li P., Nijhawan D., Budihardjo I., et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91 (1997) 479-489
6. Thornberry N.A., and Lazebnik Y. Caspases: enemies within. Science 281 (1998) 1312-1316
7. Narula J., Pandey P., Arbustini E., et al. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci U S A 96 (1999) 8144-8149
8. Haider N., Narula N., and Narula J. Apoptosis in heart failure represents programmed cell survival, not death, of cardiomyocytes and likelihood of reverse remodeling. J Card Fail 8 (2002) S512-7
9. Scheubel R.J., Bartling B., Simm A., et al. Apoptotic pathway activation from mitochondria and death receptors without caspase-3 cleavage in failing human myocardium: fragile balance of myocyte survival?. J Am Coll Cardiol 39 (2002) 481-488
10. de Boer R.A., van Veldhuisen D.J., van der Wijk J., et al. Additional use of immunostaining for active caspase 3 and cleaved actin and PARP fragments to detect apoptosis in patients with chronic heart failure. J Card Fail 6 (2000) 330-337
11. Knaapen M.W., Davies M.J., De Bie M., et al. Apoptotic versus autophagic cell death in heart failure. Cardiovasc Res 51 (2001) 304-312
12. de Jonge N., van Wichen D.F., van Kuik J., et al. Cardiomyocyte death in patients with end-stage heart failure before and after support with a left ventricular assist device: low incidence of apoptosis despite ubiquitous mediators. J Heart Lung Transplant 22 (2003) 1028-1036
13. Moorjani N., Catarino P., El-Sayed R., et al. A pressure overload model to track the molecular biology of heart failure. Eur J Cardiothorac Surg 24 (2003) 920-925
14. National Research Council. Guide for the Care and Use of Laboratory Animals (1996), National Academy Press, Washington, DC
15. Devereux R.B., Alonso D.R., Lutas E.M., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
16. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
17. Talanian R.V., Quinlan C., Trautz S., et al. Substrate specificities of caspase family proteases. J Biol Chem 272 (1997) 9677-9682
18. Green D., and Kroemer G. The central executioners of apoptosis: caspases or mitochondria?. Trends Cell Biol 8 (1998) 267-271
19. Cheng W., Li B., Kajstura J., et al. Stretch-induced programmed myocyte cell death. J Clin Invest 96 (1995) 2247-2259
20. Jiang L., Huang Y., Hunyor S., and dos Remedios C.G. Cardiomyocyte apoptosis is associated with increased wall stress in chronic failing left ventricle. Eur Heart J 24 (2003) 742-751
21. Leri A., Claudio P.P., Li Q., et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest 101 (1998) 1326-1342
22. Salvesen G.S., and Dixit V.M. Caspase activation: the induced-proximity model. Proc Natl Acad Sci U S A 96 (1999) 10964-10967
23. Narula J., Haider N., Virmani R., et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335 (1996) 1182-1189
24. Olivetti G., Abbi R., Quaini F., et al. Apoptosis in the failing human heart. N Engl J Med 336 (1997) 1131-1141
25. Kanoh M., Takemura G., Misao J., et al. Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. Circulation 99 (1999) 2757-2764
26. Lesauskaite V., Epistolato M.C., Ivanoviene L., and Tanganelli P. Apoptosis of cardiomyocytes in explanted and transplanted hearts. Comparison of results from in situ TUNEL, ISEL, and ISOL reactions. Am J Clin Pathol 121 (2004) 108-116
27. Bartunek J., Vanderheyden M., Knaapen M.W., et al. Deoxyribonucleic acid damage/repair proteins are elevated in the failing human myocardium due to idiopathic dilated cardiomyopathy. J Am Coll Cardiol 40 (2002) 1097-1103
28. Migheli A., Cavalla P., Marino S., and Schiffer D. A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks. J Neuropathol Exp Neurol 53 (1994) 606-616
29. Negoescu A., Lorimier P., Labat-Moleur F., et al. In situ apoptotic cell labeling by the TUNEL method: improvement and evaluation on cell preparations. J Histochem Cytochem 44 (1996) 959-968
30. Narula J., Arbustini E., Chandrashekhar Y., and Schwaiger M. Apoptosis and the systolic dysfunction in congestive heart failure. Story of apoptosis interruptus and zombie myocytes. Cardiol Clin 19 (2001) 113-126
31. Ruetten H., Badorff C., Ihling C., Zeiher A.M., and Dimmeler S. Inhibition of caspase-3 improves contractile recovery of stunned myocardium, independent of apoptosis-inhibitory effects. J Am Coll Cardiol 38 (2001) 2063-2070
32. Condorelli G., Roncarati R., Ross Jr. J., et al. Heart-targeted overexpression of caspase-3 in mice increases infarct size and depresses cardiac function. Proc Natl Acad Sci U S A 98 (2001) 9977-9982
33. Communal C., Sumandea M., de Tombe P., et al. Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci U S A 99 (2002) 6252-6256
34. Moretti A., Weig H.J., Ott T., et al. Essential myosin light chain as a target for caspase-3 in failing myocardium. Proc Natl Acad Sci U S A 99 (2002) 11860-11865
35. Hein S., Arnon E., Kostin S., et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107 (2003) 984-991
36. Martin D.N., and Baehrecke E.H. Caspases function in autophagic programmed cell death in Drosophila. Development 131 (2004) 275-284